# Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

> **NCT06784466** · NA · RECRUITING · sponsor: **Arga Medtech SA** · enrollment: 360 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Persistant Atrial Fibrillation
- Paroxysmal AF

## Interventions

- **DEVICE:** Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System

## Key facts

- **NCT ID:** NCT06784466
- **Lead sponsor:** Arga Medtech SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-10
- **Primary completion:** 2027-06
- **Final completion:** 2027-08
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06784466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06784466, "Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06784466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*